David A. Bellnier - Concepedia

Author

David A. Bellnier

Roswell Park Comprehensive Cancer Center ORCID

Also Known As

Bellnier, David A., D A Bellnier, D. A. Bellnier, D. Bellnier, D.A. Bellnier, DAVID A. BELLNIER, David A Bellnier, David A. Bellnier, David Bellnier

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center Orthopaedic Research Foundation Massachusetts General Hospital

About

David A. Bellnier is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, health sciences, and photodynamic therapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	24	1.9K
2	Health Sciences	20	27	2K
3	Biochemistry	7	7	528
4	Engineering	3	3	44
5	Natural Sciences	1	1	24

David A. Bellnier

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Barbara W. Henderson, Theresa M. Busch, Lurine A. Vaughan, PubMed OptogeneticsPhotofrin Photodynamic TherapyPhotochemistryOphthalmologyPhotodynamic Therapy	2000	249
DISTRIBUTION AND ELIMINATION OF PHOTOFRIN II IN MICE David A. Bellnier, Yau‐Kwan Ho, Ravindra K. Pandey, Photochemistry and Photobiology Oxidative StressSkeletal MusclePhototoxicityRadiopharmaceutical TherapyChemodynamic Therapy	1989	201
An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Barbara W. Henderson, David A. Bellnier, William R. Greco, PubMed Medicinal ChemistryPyropheophorbide DerivativesBiochemistryPhotochemistryPhotodynamic Therapy	1997	197
Synthesis, Photophysical Properties, Tumor Uptake, and Preliminary in Vivo Photosensitizing Efficacy of a Homologous Series of 3-(1‘-Alkyloxy)ethyl-3-devinylpurpurin-18-<i>N</i>-alkylimides with Variable Lipophilicity Gang Zheng, William R. Potter, Susan H. Camacho, Journal of Medicinal Chemistry	2001	190
Photodynamic therapy: a means to enhanced drug delivery to tumors. John W. Snyder, William R. Greco, David A. Bellnier, PubMed NanomedicinePhotochemistryPolymer-drug ConjugatePhotodynamic TherapyMedicine	2003	177
CHLORIN AND PORPHYRIN DERIVATIVES AS POTENTIAL PHOTOSENSITIZERS IN PHOTODYNAMIC THERAPY Ravindra K. Pandey, David A. Bellnier, Kevin M. Smith, Photochemistry and Photobiology	1991	173
Alkyl Ether Analogs of Chlorophyll‐<i>a</i> Derivatives: Part 1. Synthesis, Photophysical Properties and Photodynamic Efficacy Ravindra Kumar Pandey, Adam B. Sumlin, Scott Constantine, Photochemistry and Photobiology	1996	162
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. David A. Bellnier, William R. Greco, Gregory Loewen, PubMed Hpph InfusionPhotochemistryHealth SciencesMedicinePhotodynamic Therapy	2003	135
Photoradiation Therapy — Clinical and Drug Advances Thomas J. Dougherty, D. G. Boyle, K. R. Weishaupt, Advances in experimental medicine and biology Radiation MedicinePhotochemistryPhotodynamic TherapyPhototoxicityDrug Advances	1983	134
Toll-like Receptor 5 Agonist Protects Mice From Dermatitis and Oral Mucositis Caused by Local Radiation: Implications for Head-and-Neck Cancer Radiotherapy Lyudmila G. Burdelya, Anatoli S. Gleiberman, Ilia Toshkov, International Journal of Radiation OncologyBiologyPhysics Head-and-neck Cancer RadiotherapyRadiation TherapyRadiation EffectToll-like Receptor 5Immunology	2011	116

Page 1